Navigation Links
Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Date:9/5/2012

NEW YORK, Sept. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

http://www.reportlinker.com/p0611589/Orthobiologics-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

 

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

 

Summary

 

GlobalData's new report, "Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within four market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

 

Scope

 

- Market size data for Orthobiologics market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators.

- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the four market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.

- 2011 company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Orthobiologics market in BRICS.

- Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Medtronic, Inc., Baxter International Inc., Biomet, Inc., Orthofix International N.V., Smith & Nephew Plc, Globus Medical, Inc., Wright Medical Group, Inc., Stryker Corporation, DJO Finance LLC, Ferring International Center S.A., Seikagaku Corporation, Anika Therapeutics, Inc. and Alphatec Holdings, Inc..

 

Reasons to buy

 

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Orthobiologics competitive landscape in BRICS.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

 

 

 

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 12

2 Introduction 15

2.1 What is This Report About? 15

3 Orthobiologics in BRICS 16

3.1 Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16

3.2 Orthobiologics, BRICS, Company share (2010-2011) 21

4 Orthobiologics In Brazil 23

4.1 Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23

4.2 Bone Graft Substitutes In Brazil 28

4.2.1 Bone Graft Substitutes, Brazil, Overall Revenue (2004-2018) 28

4.2.2 Bone Graft Substitutes, Brazil, Overall Volume (2004-2018) 32

4.2.3 Bone Graft Substitutes, Brazil, Average Price (2004-2018) 35

4.3 Bone Allografts In Brazil 36

4.3.1 Bone Allografts, Brazil, Overall Revenue (2004-2018) 36

4.4 Viscosupplementation In Brazil 38

4.4.1 Viscosupplementation, Brazil, Overall Revenue (2004-2018) 38

4.4.2 Viscosupplementation, Brazil, Overall Volume (2004-2018) 40

4.4.3 Viscosupplementation, Brazil, Average Price (2004-2018) 42

4.5 Bone Growth Stimulators In Brazil 43

4.5.1 Bone Growth Stimulators, Brazil, Overall Revenue (2004-2018) 43

4.5.2 Bone Growth Stimulators, Brazil, Overall Volume (2004-2018) 45

4.5.3 Bone Growth Stimulators, Brazil, Average Price (2004-2018) 47

4.6 Orthobiologics, Brazil, Distribution Share (2010-2011) 48

4.7 Orthobiologics, Brazil, Company Share (2010-2011) 49

5 Orthobiologics In Russian Federation 51

5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 51

5.2 Bone Graft Substitutes In Russian Federation 57

5.2.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2004-2018) 57

5.2.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2004-2018) 61

5.2.3 Bone Graft Substitutes, Russian Federation, Average Price (2004-2018) 65

5.3 Bone Allografts In Russian Federation 66

5.3.1 Bone Allografts, Russian Federation, Overall Revenue (2004-2018) 66

5.4 Bone Growth Stimulators In Russian Federation 68

5.4.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2004-2018) 68

5.4.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2004-2018) 71

5.4.3 Bone Growth Stimulators, Russian Federation, Average Price (2004-2018) 73

5.5 Viscosupplementation In Russian Federation 74

5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2004-2018) 74

5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2004-2018) 77

5.5.3 Viscosupplementation, Russian Federation, Average Price (2004-2018) 79

5.6 Orthobiologics, Russian Federation, Distribution Share (2010-2011) 80

5.7 Orthobiologics, Russian Federation, Company Share (2010-2011) 81

6 Orthobiologics In India 83

6.1 Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83

6.2 Bone Graft Substitutes In India 88

6.2.1 Bone Graft Substitutes, India, Overall Revenue (2004-2018) 88

6.2.2 Bone Graft Substitutes, India, Overall Volume (2004-2018) 92

6.2.3 Bone Graft Substitutes, India, Average Price (2004-2018) 95

6.3 Bone Allografts In India 96

6.3.1 Bone Allografts, India, Overall Revenue (2004-2018) 96

6.4 Viscosupplementation In India 98

6.4.1 Viscosupplementation, India, Overall Revenue (2004-2018) 98

6.4.2 Viscosupplementation, India, Overall Volume (2004-2018) 100

6.4.3 Viscosupplementation, India, Average Price (2004-2018) 102

6.5 Bone Growth Stimulators In India 103

6.5.1 Bone Growth Stimulators, India, Overall Revenue (2004-2018) 103

6.5.2 Bone Growth Stimulators, India, Overall Volume (2004-2018) 105

6.5.3 Bone Growth Stimulators, India, Average Price (2004-2018) 107

6.6 Orthobiologics, India, Distribution Share (2010-2011) 108

6.7 Orthobiologics, India, Company Share (2010-2011) 109

7 Orthobiologics In China 111

7.1 Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111

7.2 Bone Graft Substitutes In China 116

7.2.1 Bone Graft Substitutes, China, Overall Revenue (2004-2018) 116

7.2.2 Bone Graft Substitutes, China, Overall Volume (2004-2018) 120

7.2.3 Bone Graft Substitutes, China, Average Price (2004-2018) 123

7.3 Bone Allografts In China 124

7.3.1 Bone Allografts, China, Overall Revenue (2004-2018) 124

7.4 Viscosupplementation In China 126

7.4.1 Viscosupplementation, China, Overall Revenue (2004-2018) 126

7.4.2 Viscosupplementation, China, Overall Volume (2004-2018) 128

7.4.3 Viscosupplementation, China, Average Price (2004-2018) 130

7.5 Bone Growth Stimulators In China 131

7.5.1 Bone Growth Stimulators, China, Overall Revenue (2004-2018) 131

7.5.2 Bone Growth Stimulators, China, Overall Volume (2004-2018) 133

7.5.3 Bone Growth Stimulators, China, Average Price (2004-2018) 135

7.6 Orthobiologics, China, Distribution Share (2010-2011) 136

7.7 Orthobiologics, China, Company Share (2010-2011) 137

8 Orthobiologics In South Africa 139

8.1 Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139

8.2 Bone Graft Substitutes In South Africa 145

8.2.1 Bone Graft Substitutes, South Africa, Overall Revenue (2004-2018) 145

8.2.2 Bone Graft Substitutes, South Africa, Overall Volume (2004-2018) 149

8.2.3 Bone Graft Substitutes, South Africa, Average Price (2004-2018) 153

8.3 Bone Allografts In South Africa 154

8.3.1 Bone Allografts, South Africa, Overall Revenue (2004-2018) 154

8.4 Viscosupplementation In South Africa 156

8.4.1 Viscosupplementation, South Africa, Overall Revenue (2004-2018) 156

8.4.2 Viscosupplementation, South Africa, Overall Volume (2004-2018) 158

8.4.3 Viscosupplementation, South Africa, Average Price (2004-2018) 160

8.5 Bone Growth Stimulators In South Africa 161

8.5.1 Bone Growth Stimulators, South Africa, Overall Revenue (2004-2018) 161

8.5.2 Bone Growth Stimulators, South Africa, Overall Volume (2004-2018) 165

8.5.3 Bone Growth Stimulators, South Africa, Average Price (2004-2018) 167

8.6 Orthobiologics, South Africa, Distribution Share (2010-2011) 168

8.7 Orthobiologics, South Africa, Company Share (2010-2011) 169

9 Overview of Key Companies in BRICS Orthobiologics Market 171

9.1 DePuy, Inc. 171

9.1.1 Company Overview 171

9.1.2 Share in the BRICS Orthobiologics Market 172

9.2 Genzyme Corporation 173

9.2.1 Company Overview 173

9.2.2 Share in the BRICS Orthobiologics Market 174

9.3 Synthes, Inc. 175

9.3.1 Company Overview 175

9.3.2 Share in the BRICS Orthobiologics Market 176

9.4 Medtronic, Inc. 177

9.4.1 Company Overview 177

9.4.2 Share in the BRICS Orthobiologics Market 178

9.5 Baxter International Inc. 179

9.5.1 Company Overview 179

9.5.2 Share in the BRICS Orthobiologics Market 180

9.6 Biomet, Inc. 181

9.6.1 Company Overview 181

9.6.2 Share in the BRICS Orthobiologics Market 182

9.7 Orthofix International N.V. 183

9.7.1 Company Overview 183

9.7.2 Share in the BRICS Orthobiologics Market 184

9.8 Smith & Nephew Plc 185

9.8.1 Company Overview 185

9.8.2 Share in the BRICS Orthobiologics Market 186

9.9 Globus Medical, Inc. 187

9.9.1 Company Overview 187

9.10 Wright Medical Group, Inc. 188

9.10.1 Company Overview 188

9.10.2 Share in the BRICS Orthobiologics Market 189

9.11 Stryker Corporation 190

9.11.1 Company Overview 190

9.11.2 Share in the BRICS Orthobiologics Market 191

9.12 DJO Finance LLC 192

9.12.1 Company Overview 192

9.12.2 Share in the BRICS Orthobiologics Market 193

9.13 Ferring International Center S.A. 194

9.13.1 Company Overview 194

9.13.2 Share in the BRICS Orthobiologics Market 195

9.14 Seikagaku Corporation 196

9.14.1 Company Overview 196

9.15 Anika Therapeutics, Inc. 197

9.15.1 Company Overview 197

9.15.2 Share in the BRICS Orthobiologics Market 198

9.16 Alphatec Holdings, Inc. 199

9.16.1 Company Overview 199

9.16.2 Share in the BRICS Orthobiologics Market 200

9.17 NuVasive, Inc. 201

9.17.1 Company Overview 201

10 Appendix 202

10.1 Definitions of Markets Covered in the Report 203

10.1.1 Orthobiologics 203

10.2 Research Methodology 204

10.3 Secondary Research 204

10.4 Primary Research 205

10.5 Models 205

10.6 Forecasts 206

10.7 Expert Panels 206

10.8 GlobalData Consulting 206

10.9 Currency Conversion 207

10.10 Contact Us 207

10.11 Disclaimer 207

 

List of Tables

 

Table 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16

Table 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18

Table 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20

Table 4: Orthobiologics, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 22

Table 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23

Table 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25

Table 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27

Table 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 29

Table 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 31

Table 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 33

Table 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34

Table 12: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2004-2011 35

Table 13: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2011-2018 35

Table 14: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36

Table 15: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37

Table 16: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38

Table 17: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39

Table 18: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40

Table 19: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41

Table 20: Viscosupplementation, Brazil, Average Price ($), Historic, 2004-2011 42

Table 21: Viscosupplementation, Brazil, Average Price ($), Forecast, 2011-2018 42

Table 22: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43

Table 23: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 44

Table 24: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45

Table 25: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46

Table 26: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2004-2011 47

Table 27: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2011-2018 47

Table 28: Orthobiologics, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 48

Table 29: Orthobiologics, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 50

Table 30: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 52

Table 31: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 54

Table 32: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 56

Table 33: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 58

Table 34: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 60

Table 35: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 62

Table 36: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 64

Table 37: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2004-2011 65

Table 38: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2011-2018 65

Table 39: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 66

Table 40: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 67

Table 41: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 69

Table 42: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 70

Table 43: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71

Table 44: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72

Table 45: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2004-2011 73

Table 46: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2011-2018 73

Table 47: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 75

Table 48: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 76

Table 49: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77

Table 50: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78

Table 51: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2004-2011 79

Table 52: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2011-2018 79

Table 53: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 80

Table 54: Orthobiologics, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 82

Table 55: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83

Table 56: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 85

Table 57: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 87

Table 58: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 89

Table 59: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 91

Table 60: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 93

Table 61: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94

Table 62: Bone Graft Substitutes, India, Average Price ($), Historic, 2004-2011 95

Table 63: Bone Graft Substitutes, India, Average Price ($), Forecast, 2011-2018 95

Table 64: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96

Table 65: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97

Table 66: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98

Table 67: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99

Table 68: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100

Table 69: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101

Table 70: Viscosupplementation, India, Average Price ($), Historic, 2004-2011 102

Table 71: Viscosupplementation, India, Average Price ($), Forecast, 2011-2018 102

Table 72: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103

Table 73: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018 104

Table 74: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105

Table 75: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106

Table 76: Bone Growth Stimulators, India, Average Price ($), Historic, 2004-2011 107

Table 77: Bone Growth Stimulators, India, Average Price ($), Forecast, 2011-2018 107

Table 78: Orthobiologics, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 108

Table 79: Orthobiologics, India, Company Share by Revenue ($m), USD Constant, 2010-2011 110

Table 80: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111

Table 81: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 113

Table 82: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 115

Table 83: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 117

Table 84: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 119

Table 85: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 121

Table 86: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122

Table 87: Bone Graft Substitutes, China, Average Price ($), Historic, 2004-2011 123

Table 88: Bone Graft Substitutes, China, Average Price ($), Forecast, 2011-2018 123

Table 89: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124

Table 90: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125

Table 91: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126

Table 92: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127

Table 93: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128

Table 94: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129

Table 95: Viscosupplementation, China, Average Price ($), Historic, 2004-2011 130

Table 96: Viscosupplementation, China, Average Price ($), Forecast, 2011-2018 130

Table 97: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011 131

Table 98: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018 132

Table 99: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133

Table 100: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134

Table 101: Bone Growth Stimulators, China, Average Price ($), Historic, 2004-2011 135

Table 102: Bone Growth Stimulators, China, Average Price ($), Forecast, 2011-2018 135

Table 103: Orthobiologics, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 136

Table 104: Orthobiologics, China, Company Share by Revenue ($m), USD Constant, 2010-2011 138

Table 105: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 140

Table 106: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 142

Table 107: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 144

Table 108: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 146

Table 109: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 148

Table 110: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011 150

Table 111: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 152

Table 112: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2004-2011 153

Table 113: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2011-2018 153

Table 114: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154

Table 115: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155

Table 116: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 156

Table 117: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 157

Table 118: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158

Table 119: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159

Table 120: Viscosupplementation, South Africa, Average Price ($), Historic, 2004-2011 160

Table 121: Viscosupplementation, South Africa, Average Price ($), Forecast, 2011-2018 160

Table 122: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 162

Table 123: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 164

Table 124: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165

Table 125: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166

Table 126: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2004-2011 167

Table 127: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2011-2018 167

Table 128: Orthobiologics, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 168

Table 129: Orthobiologics, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 170

Table 130: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 172

Table 131: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 174

Table 132: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 176

Table 133: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 178

Table 134: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 180

Table 135: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 182

Table 136: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2011 184

Table 137: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2011 186

Table 138: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 187

Table 139: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 189

Table 140: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 191

Table 141: DJO Finance LLC, Revenue ($m), BRICS Orthobiologics Market, 2011 193

Table 142: Ferring International Center S.A., Revenue ($m), BRICS Orthobiologics Market, 2011 195

Table 143: Seikagaku Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 196

Table 144: Anika Therapeutics, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 198

Table 145: Alphatec Holdings, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 200

 

List of Figures

 

Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16

Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17

Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19

Figure 4: Orthobiologics, BRICS, Company share (%), 2011 21

Figure 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23

Figure 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24

Figure 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26

Figure 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 28

Figure 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 30

Figure 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 32

Figure 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34

Figure 12: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36

Figure 13: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37

Figure 14: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38

Figure 15: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39

Figure 16: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40

Figure 17: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41

Figure 18: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43

Figure 19: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 44

Figure 20: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45

Figure 21: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46

Figure 22: Orthobiologics, Brazil, Company Share (%), 2011 49

Figure 23: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 51

Figure 24: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 53

Figure 25: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 55

Figure 26: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 57

Figure 27: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 59

Figure 28: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 61

Figure 29: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 63

Figure 30: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 66

Figure 31: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 67

Figure 32: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 68

Figure 33: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 70

Figure 34: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71

Figure 35: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72

Figure 36: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 74

Figure 37: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 76

Figure 38: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77

Figure 39: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78

Figure 40: Orthobiologics, Russian Federation, Company Share (%), 2011 81

Figure 41: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83

Figure 42: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 84

Figure 43: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 86

Figure 44: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 88

Figure 45: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 90

Figure 46: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 92

Figure 47: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94

Figure 48: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96

Figure 49: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97

Figure 50: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98

Figure 51: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99

Figure 52: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100

Figure 53: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101

Figure 54: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103

Figure 55: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018 104

Figure 56: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105

Figure 57: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106

Figure 58: Orthobiologics, India, Company Share (%), 2011 109

Figure 59: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111

Figure 60: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 112

Figure 61: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 114

Figure 62: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 116

Figure 63: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 118

Figure 64: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 120

Figure 65: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122

Figure 66: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124

Figure 67: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125

Figure 68: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126

Figure 69: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127

Figure 70: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128

Figure 71: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129

Figure 72: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011 131

Figure 73: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018 132

Figure 74: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133

Figure 75: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134

Figure 76: Orthobiologics, China, Company Share (%), 2011 137

Figure 77: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139

Figure 78: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 141

Figure 79: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 143

Figure 80: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 145

Figure 81: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 147

Figure 82: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011 149

Figure 83: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 151

Figure 84: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154

Figure 85: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155

Figure 86: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 156

Figure 87: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 157

Figure 88: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158

Figure 89: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159

Figure 90: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 161

Figure 91: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 163

Figure 92: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165

Figure 93: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166

Figure 94: Orthobiologics, South Africa, Company Share (%), 2011 169

Figure 95: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 172

Figure 96: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2011 174

Figure 97: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 176

Figure 98: Medtronic, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 178

Figure 99: Baxter International Inc., Company Share (%), BRICS Orthobiologics Market, 2011 180

Figure 100: Biomet, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 182

Figure 101: Orthofix International N.V., Company Share (%), BRICS Orthobiologics Market, 2011 184

Figure 102: Smith & Nephew Plc, Company Share (%), BRICS Orthobiologics Market, 2011 186

Figure 103: Wright Medical Group, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 189

Figure 104: Stryker Corporation, Company Share (%), BRICS Orthobiologics Market, 2011 191

Figure 105: DJO Finance LLC, Company Share (%), BRICS Orthobiologics Market, 2011 193

Figure 106: Ferring International Center S.A., Company Share (%), BRICS Orthobiologics Market, 2011 195

Figure 107: Anika Therapeutics, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 198

Figure 108: Alphatec Holdings, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 200

 

Companies mentioned

DePuy, Inc.

Genzyme Corporation

Synthes, Inc.

Medtronic, Inc.

Baxter International Inc.

Biomet, Inc.

Orthofix International N.V.

Smith & Nephew Plc

Globus Medical, Inc.

Wright Medical Group, Inc.

Stryker Corporat

 

 

 

To order this report:

Orthopedic Industry: Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related biology news :

1. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
2. New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
3. M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
4. 2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
5. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
6. Climate change may create price volatility in the corn market, say Stanford and Purdue researchers
7. Understanding the RNAi Reagents Market Overlap with Drug Discovery and Therapeutic Development is Critical for Pharmaceutical Leaders
8. Biometric Market Forecast to 2014
9. MEMS Market Triples 2009-2011, to Reach $5.4 Billion in 2017
10. PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDSs Marketplace 2012 Trade Convention
11. TREW Marketing Webcast Shows B2B Companies How to Reach Technical Audiences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2016)... -- ABI Research, the leader in transformative technology ... will reach more than $30 billion by 2021, ... electronics, particularly smartphones, continue to boost the biometrics ... two billion shipments by 2021 at a 40% ... Analyst at ABI Research. "Surveillance is also gearing ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/10/2016)...   Unisys Corporation (NYSE: UIS ) today ... is testing its biometric identity solution at the Otay Mesa ... help identify certain non-U.S. citizens leaving the country. ... help determine the efficiency and accuracy of using biometric technologies ... run until May 2016. --> the United ...
Breaking Biology News(10 mins):
(Date:5/18/2016)... (PRWEB) , ... May 18, 2016 , ... ... 1,200 hospitalizations are a direct result of asthma complications.* Costing more than $56 ... the country. , “For too many, the suffering associated with ...
(Date:5/18/2016)... ... May 18, 2016 , ... Ryan Benton was diagnosed with ... in the late teens to early twenties. DMD is a relatively common progressive genetic ... age of 22, Benton’s condition was critical. He met with the founder of the ...
(Date:5/17/2016)... , ... May 17, 2016 , ... ... in animal waste reduction applications, announced today it will be showcasing ManureMagic™ at ... , ManureMagic™ was featured in the Wall Street Journal last year and more ...
(Date:5/17/2016)... ... May 17, 2016 , ... PATH and Laerdal Global ... to bring a feeding cup to market based on a reference design co-developed ... at Seattle Children’s Hospital, thereby ensuring an innovative feeding option for the 7.6 ...
Breaking Biology Technology: